Insider Transactions in Q1 2022 at Revolution Medicines, Inc. (RVMD)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
725
+0.07%
|
$17,400
$24.71 P/Share
|
|
Mar 25
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
42,000
+2.13%
|
$1,008,000
$24.93 P/Share
|
|
Mar 24
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
49,119
+5.02%
|
$1,178,856
$24.26 P/Share
|
|
Mar 23
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
53,118
+2.95%
|
$1,221,714
$23.8 P/Share
|
|
Mar 22
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
130,127
+5.09%
|
$2,992,921
$23.01 P/Share
|
|
Mar 21
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
75,731
+4.92%
|
$1,514,620
$20.97 P/Share
|
|
Mar 18
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
82,200
+6.01%
|
$1,561,800
$19.83 P/Share
|
|
Mar 17
2022
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
159
-0.79%
|
$2,862
$18.62 P/Share
|
|
Mar 17
2022
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
1,023
-0.55%
|
$18,414
$18.61 P/Share
|
|
Mar 17
2022
|
Xiaolin Wang |
SELL
Open market or private sale
|
Direct |
240
-0.75%
|
$4,320
$18.61 P/Share
|
|
Mar 17
2022
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
321
-0.11%
|
$5,778
$18.62 P/Share
|
|
Mar 17
2022
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
321
-0.5%
|
$5,778
$18.61 P/Share
|
|
Mar 17
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
10,120
+1.85%
|
$182,160
$18.78 P/Share
|
|
Mar 11
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
3,110
+0.59%
|
$62,200
$20.93 P/Share
|
|
Mar 10
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
40,400
+3.62%
|
$808,000
$20.9 P/Share
|
|
Mar 09
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
39,600
+7.55%
|
$792,000
$20.07 P/Share
|
|
Mar 08
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
103,833
+7.7%
|
$1,972,827
$19.16 P/Share
|
|
Mar 07
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
103,005
+12.17%
|
$1,854,090
$18.63 P/Share
|
|
Mar 04
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
56,300
+19.12%
|
$957,100
$17.69 P/Share
|
|
Mar 03
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
65,637
+14.95%
|
$1,181,466
$18.78 P/Share
|
|
Mar 02
2022
|
Thilo Schroeder |
BUY
Open market or private purchase
|
Indirect |
116,290
+50.0%
|
$2,093,220
$18.94 P/Share
|
|
Mar 01
2022
|
Xiaolin Wang |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+38.51%
|
-
|
|
Mar 01
2022
|
Jack Anders Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,600
+36.67%
|
-
|
|
Mar 01
2022
|
Margaret A Horn Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38,800
+37.63%
|
-
|
|
Mar 01
2022
|
Stephen Michael Kelsey |
BUY
Grant, award, or other acquisition
|
Direct |
38,800
+11.78%
|
-
|
|
Mar 01
2022
|
Mark A Goldsmith |
BUY
Grant, award, or other acquisition
|
Direct |
104,000
+35.79%
|
-
|